Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ALS Society of Newfoundland and Labrador is a charitable organization dedicated to improving the lives of people living with Amyotrophic Lateral Sclerosis (ALS) in the province of Newfoundland and Labrador. The society operates an extensive equipment loan program that provides assistive devices, such as power wheelchairs and communication aids, to patients at no cost. In addition to direct patient support, the organization facilitates support groups and provides educational resources for caregivers and healthcare professionals. While the society does not engage in direct clinical research, it partners with ALS Canada to fund national research initiatives aimed at finding a cure. The organization is primarily funded through community events, such as the annual Walk to End ALS.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALS Society of Newfoundland and Labrador.